Targeted Lipid Transfer Nanoshuttle via Lipid‐Specific Transcytosis Induces Atherosclerotic Plaque Regression
Advanced Materials · 2026
DOI: 10.1002/adma.202511606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Shuling Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Transcytosis, Metal Nanoparticles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Key Research and Development Program of Zhejiang Province, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Lipid transfer proteins (LTPs) orchestrate inter‐membrane lipid transport through hydrophobic cavities, but their therapeutic application is limited by the requirement to simultaneously maintain dual‐membrane targeting and lipid‐carrying structures. Inspired by LTPs, a therapeutic platform coupling β‐cyclodextrin (β‐CD) with gold nanoparticles as a lipid‐capturing shuttle (LipShuttle) is proposed. The β‐CD specifically targets lipid droplets to sequester stored lipids, while the gold nanoparticles drive transcytotic lipid efflux. This dual mechanism enhances lipid removal, boosts neutral lipid catabolism, and reverses lipid overload in foam cells. Then LipShuttle's therapeutic efficacy is validated in high‐fat diet‐fed ApoE − / − mice with established atherosclerotic plaques. By combining ultrasound‐enhanced lipid efflux with cell targeting, LipShuttle promotes plaque regression and reduces vulnerability. Mechanistically, LipShuttle‐mediated lipid depletion suppresses arachidonic acid metabolism, attenuating inflammation, and reprograms plaque macrophages toward a pro‐efferocytic phenotype. This dual action promotes plaque regression, demonstrating a promising lipid transfer‐based therapeutic strategy for diseases driven by dysregulated lipid accumulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Zhejiang University, Hangzhou, 310058, China.
- Qiushi Academy for Advanced Studies, Zhejiang University, Hangzhou, 310058, China.
- Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, 310016, China.
- Institute of Fundamental and Transdisciplinary Research, Zhejiang University, Hangzhou, 310058, China.
- Department of Cardiology,Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310016, China.
- Research Centre of Clinical Pharmacy of The First Affiliated Hospital & Liangzhu Laboratory, School of Medicine, Zhejiang University, Hangzhou, 311121, China.
ORCID-Profile: Ruikang Tang, Xiaoyu Wang
Förderung
- Key Research and Development Program of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Science and Technology Project of Zhejiang Province
Zitieren
APA
Tang, S., Cui, Y., Xiao, Y., Li, W., Zhou, Y., Li, C., Ma, B., Li, C., Li, B., Fu, G., Tang, R., & Wang, X. (2026). Targeted Lipid Transfer Nanoshuttle via Lipid‐Specific Transcytosis Induces Atherosclerotic Plaque Regression. Advanced Materials. https://doi.org/10.1002/adma.202511606
Vancouver
Tang S, Cui Y, Xiao Y, Li W, Zhou Y, Li C, et al. Targeted Lipid Transfer Nanoshuttle via Lipid‐Specific Transcytosis Induces Atherosclerotic Plaque Regression. Advanced Materials. 2026. doi:10.1002/adma.202511606
BibTeX
@article{Tang2026,
author = {Tang, Shuling and Cui, Yihao and Xiao, Yun and Li, Wujiao and Zhou, Yuemin and Li, Chen and Ma, Boxuan and Li, Chengbin and Li, Benke and Fu, Guosheng and Tang, Ruikang and Wang, Xiaoyu},
title = {Targeted Lipid Transfer Nanoshuttle via Lipid‐Specific Transcytosis Induces Atherosclerotic Plaque Regression},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202511606}
}
EUVIMED